Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people

Age is the strongest determinant of COVID-19 mortality, and over 2 billion people have received primary series vaccination with BNT162b2 (mRNA) or ChAdOx1 (adenoviral vector). However, the profile of sustained vaccine immunogenicity in older people is unknown. Here, we determine spike-specific humor...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Helen, Bruton, Rachel, Ayodele, Reni, Sylla, Penny, McIlroy, Graham, Logan, Nicola, Scott, Sam, Nicol, Sam, Verma, Kriti, Stephens, Christine, Willett, Brian, Zuo, Jianmin, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404227/
https://www.ncbi.nlm.nih.gov/pubmed/36075216
http://dx.doi.org/10.1016/j.xcrm.2022.100739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404227/
https://www.ncbi.nlm.nih.gov/pubmed/36075216
http://dx.doi.org/10.1016/j.xcrm.2022.100739

Ejemplares similares